Tel-Aviv, Israel, April 30, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of ...

should be given on a Supplemental Form 8 (Open Positions). Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b ...

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions) ...

For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each ...

For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each ...

Samson Rock Capital LLP - Form 8.3 - International Distribution Services Plc PR Newswire LONDON, United Kingdom, April 28 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON ...

Samson Rock Capital LLP - Form 8.3 - Care REIT plc PR Newswire LONDON, United Kingdom, April 29 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN ...

Tel-Aviv, Israel, April 30, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay” or the "Company”), a renewable energy and power generator and developer of renewable ...

However, it was clear that he felt frustrated by the responses and guidance he received from the Capital Asset Management and Maintenance Division of the Department of Administration (DCAMM).

The value of the parking spaces in 2025 was determined by the Division of Capital Asset Management and Maintenance to be $477 per month. Based on that figure, legislators would be taxed on the ...

However, that has been scuppered by the FDA requiring fast-track status that is specific to the subcutaneous form. In a statement, Eisai and Biogen said a fast-track application has now been filed ...